Prostate tumor volumes were significantly smaller in L1-treated Myc-CaP animals (p < 0.01) compared with control mice, and consistent with our hypothesis, L1 exhibited a higher efficacy in the low-iron TRAMP-C2 models determined by comparison of endpoint volumes (Fig. 4b, p < 0.001). Here, MYC is linked to prostate neoplasm.